DOI: 10.1097/01.NT.0000367459.43074.73

,  

Issn Print: 1533-7006

Publication Date: 2010/01/07


Print

Drug Study Is Latest to Show Improved Cognition in Mouse Model for Down Syndrome

DAN HURLEY

    loading  Checking for direct PDF access through Ovid

Excerpt

Investigators reported that when Ts65Dn mice were treated with a combination of drugs that restored norepinephrine concentrations in the hippocampus, learning and memory deficits associated with impaired hippocampal function were alleviated.
    loading  Loading Related Articles